Metastatic Renal Cell Carcinoma Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

Also known as: Metastatic Renal cell carcinoma

IndicationStatusPhase
DBCOND0030098 (Metastatic Renal Cell Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02298959Pembrolizumab and Ziv-aflibercept in Treating Patients With Advanced Solid TumorsTreatment